Cargando…

Cardiac Effects of a Single Dose of Pimobendan in Cats With Hypertrophic Cardiomyopathy; A Randomized, Placebo-Controlled, Crossover Study

Background: Pimobendan has been shown to impart a significant survival benefit in cardiomyopathic cats who receive it as part of heart failure therapy. However, use of pimobendan remains controversial in cats with hypertrophic cardiomyopathy (HCM) due to lack of pharmacodynamic data for pimobendan i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oldach, Maureen S., Ueda, Yu, Ontiveros, Eric S., Fousse, Samantha L., Harris, Samantha P., Stern, Joshua A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Veterinary Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369151/ https://www.ncbi.nlm.nih.gov/pubmed/30778391 http://dx.doi.org/10.3389/fvets.2019.00015

Ejemplares similares

Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy
por: Oldach, Maureen S., et al.
Publicado: (2021)

Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C
por: Stern, Joshua A., et al.
Publicado: (2023)

A genetic polymorphism in P2RY(1) impacts response to clopidogrel in cats with hypertrophic cardiomyopathy
por: Ueda, Yu, et al.
Publicado: (2021)

Acute Effects of Pimobendan on Cardiac Function in Dogs With Tachycardia Induced Dilated Cardiomyopathy: A Randomized, Placebo-Controlled, Crossover Study
por: Abbott-Johnson, Kaitlin, et al.
Publicado: (2021)

Pharmacokinetics of a single dose of Aficamten (CK‐274) on cardiac contractility in a A31P MYBPC3 hypertrophic cardiomyopathy cat model
por: Sharpe, Ashley N., et al.
Publicado: (2022)

Heritability and Pedigree Analyses of Hypertrophic Cardiomyopathy in Rhesus Macaques (Macaca Mulatta)
por: Ueda, Yu, et al.
Publicado: (2021)

Repeated-Dose Pharmacodynamics of Pimobendan in Healthy Cats
por: Sugimoto, Keisuke, et al.
Publicado: (2022)

Ambulatory electrocardiography, heart rate variability, and pharmacologic stress testing in cats with subclinical hypertrophic cardiomyopathy
por: Walker, Ashley L., et al.
Publicado: (2022)

Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs
por: Pichayapaiboon, Poonavit, et al.
Publicado: (2021)

Congenital Cardiac Outflow Tract Abnormalities in Dogs: Prevalence and Pattern of Inheritance From 2008 to 2017
por: Ontiveros, Eric S., et al.
Publicado: (2019)

Pharmacokinetics of Pimobendan and Its Metabolite O-Desmethyl-Pimobendan Following Rectal Administration to Healthy Dogs
por: Her, Jiwoong, et al.
Publicado: (2020)

Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathy
por: Sharpe, Ashley N., et al.
Publicado: (2023)

Effects of pimobendan on left atrial transport function in cats
por: Kochie, Samantha L., et al.
Publicado: (2020)

Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Cats With Hypertrophic Cardiomyopathy
por: Fries, Ryan C., et al.
Publicado: (2022)

Circulating neutrophil extracellular traps in cats with hypertrophic cardiomyopathy and cardiogenic arterial thromboembolism
por: Li, Ronald H. L., et al.
Publicado: (2023)

Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2020)

Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet‐dependent thrombin generation in cats
por: Lo, Sara T., et al.
Publicado: (2023)

Analysis of the Serum Peptidomics Profile for Cats With Sarcomeric Gene Mutation and Hypertrophic Cardiomyopathy
por: Sukumolanan, Pratch, et al.
Publicado: (2021)

Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double‐blind, randomized, nonpivotal, exploratory field study
por: Schober, Karsten E., et al.
Publicado: (2021)

A One Health Approach to Hypertrophic Cardiomyopathy
por: Ueda, Yu, et al.
Publicado: (2017)

Effect of standard‐dose and high‐dose pimobendan on select indices of renal and cardiac function in dogs with American College of Veterinary Internal Medicine stage B2 myxomatous mitral valve disease
por: Kaplan, Joanna L., et al.
Publicado: (2022)

Hemodynamic effect of pimobendan following intramuscular and intravenous administration in healthy dogs: A pilot study
por: Enokizono, Masayuki, et al.
Publicado: (2022)

The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study
por: Klein, Stephanie, et al.
Publicado: (2021)

Comparison of the effects of long-term pimobendan and benazepril administration in normal cats
por: MIYAGAWA, Yuichi, et al.
Publicado: (2016)

Echocardiographic Assessment of Right Ventricular Size and Function in Cats With Hypertrophic Cardiomyopathy
por: Visser, L.C., et al.
Publicado: (2017)

Platelet Activation in Cats with Hypertrophic Cardiomyopathy
por: Tablin, F., et al.
Publicado: (2014)

Cardiac Troponin I and T as Prognostic Markers in Cats with Hypertrophic Cardiomyopathy
por: Langhorn, R., et al.
Publicado: (2014)

Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy
por: Hori, Yasutomo, et al.
Publicado: (2018)

Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy
por: Fries, Ryan C., et al.
Publicado: (2021)

Development of plasma and whole blood taurine reference ranges and identification of dietary features associated with taurine deficiency and dilated cardiomyopathy in golden retrievers: A prospective, observational study
por: Ontiveros, Eric S., et al.
Publicado: (2020)

Prominent J wave in cats with hypertrophic cardiomyopathy
por: ELSHARKAWY, Samar H., et al.
Publicado: (2021)

Comparative cardiac macroscopic and microscopic study in cats with hyperthyroidism vs. cats with hypertrophic cardiomyopathy
por: Janus, Izabela, et al.
Publicado: (2023)

A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy
por: Stern, Joshua A., et al.
Publicado: (2016)

Plasma Cardiac Troponin I Concentration and Cardiac Death in Cats with Hypertrophic Cardiomyopathy
por: Borgeat, K., et al.
Publicado: (2014)

Cardiac troponin I in healthy Norwegian Forest Cat, Birman and domestic shorthair cats, and in cats with hypertrophic cardiomyopathy
por: Hanås, Sofia, et al.
Publicado: (2022)

Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus
por: Langhorn, R., et al.
Publicado: (2017)

Speckle tracking echocardiography in cats with preclinical hypertrophic cardiomyopathy
por: Spalla, Ilaria, et al.
Publicado: (2019)

Comparative Assessment of Heart Rate Variability Obtained via Ambulatory ECG and Polar Heart Rate Monitors in Healthy Cats: A Pilot Study
por: Grigg, Emma K., et al.
Publicado: (2021)

Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study
por: Willcox, Jennifer Lindley, et al.
Publicado: (2020)

Inotropic effects of a single intravenous recommended dose of pimobendan in healthy dogs
por: HORI, Yasutomo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aeap3r3esrvpbrea824gqi9o9s